197 related articles for article (PubMed ID: 17158653)
21. Membrane-type-1 matrix metalloproteinase transcription and translation in myocardial fibroblasts from patients with normal left ventricular function and from patients with cardiomyopathy.
Spruill LS; Lowry AS; Stroud RE; Squires CE; Mains IM; Flack EC; Beck C; Ikonomidis JS; Crumbley AJ; McDermott PJ; Spinale FG
Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1362-73. PubMed ID: 17670887
[TBL] [Abstract][Full Text] [Related]
22. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy.
Li YY; Feng YQ; Kadokami T; McTiernan CF; Draviam R; Watkins SC; Feldman AM
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12746-51. PubMed ID: 11070088
[TBL] [Abstract][Full Text] [Related]
23. Long-term MMP inhibition by doxycycline exerts divergent effect on ventricular extracellular matrix deposition and systolic performance in stroke-prone spontaneously hypertensive rats.
Zeng S; Zhou X; Tu Y; Yao M; Han ZQ; Gao F; Li YM
Clin Exp Hypertens; 2011; 33(5):316-24. PubMed ID: 21649529
[TBL] [Abstract][Full Text] [Related]
24. MEK1-induced physiological hypertrophy inhibits chronic post-myocardial infarction remodeling in mice.
Yeh CC; Malhotra D; Yang YL; Xu Y; Fan Y; Li H; Mann MJ
J Cell Biochem; 2013 Jan; 114(1):47-55. PubMed ID: 22821618
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis.
Friehs I; Margossian RE; Moran AM; Cao-Danh H; Moses MA; del Nido PJ
Basic Res Cardiol; 2006 May; 101(3):204-13. PubMed ID: 16369727
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase-9 deletion attenuates myocardial fibrosis and diastolic dysfunction in ageing mice.
Chiao YA; Ramirez TA; Zamilpa R; Okoronkwo SM; Dai Q; Zhang J; Jin YF; Lindsey ML
Cardiovasc Res; 2012 Dec; 96(3):444-55. PubMed ID: 22918978
[TBL] [Abstract][Full Text] [Related]
27. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
[TBL] [Abstract][Full Text] [Related]
28. Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation.
Nishikawa N; Yamamoto K; Sakata Y; Mano T; Yoshida J; Miwa T; Takeda H; Hori M; Masuyama T
Cardiovasc Res; 2003 Mar; 57(3):766-74. PubMed ID: 12618238
[TBL] [Abstract][Full Text] [Related]
29. [Myocardial matrix metalloproteinases activities in mice with viral myocarditis and their relationship with cardiac function and myocardial collagen amount].
Meng XH; Wang Y; Zhuang JX; Chen Y; Jin YP; Han XZ; Wang YL
Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):605-8. PubMed ID: 15347449
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin type 2 receptor stimulation ameliorates left ventricular fibrosis and dysfunction via regulation of tissue inhibitor of matrix metalloproteinase 1/matrix metalloproteinase 9 axis and transforming growth factor β1 in the rat heart.
Lauer D; Slavic S; Sommerfeld M; Thöne-Reineke C; Sharkovska Y; Hallberg A; Dahlöf B; Kintscher U; Unger T; Steckelings UM; Kaschina E
Hypertension; 2014 Mar; 63(3):e60-7. PubMed ID: 24379181
[TBL] [Abstract][Full Text] [Related]
31. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction.
Mukherjee R; Mingoia JT; Bruce JA; Austin JS; Stroud RE; Escobar GP; McClister DM; Allen CM; Alfonso-Jaume MA; Fini ME; Lovett DH; Spinale FG
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2216-28. PubMed ID: 16766634
[TBL] [Abstract][Full Text] [Related]
32. MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin.
Parente JM; Blascke de Mello MM; Silva PHLD; Omoto ACM; Pernomian L; Oliveira IS; Mahmud Z; Fazan R; Arantes EC; Schulz R; Castro MM
Biochem Pharmacol; 2021 Nov; 193():114744. PubMed ID: 34453903
[TBL] [Abstract][Full Text] [Related]
33. N-terminal truncated intracellular matrix metalloproteinase-2 induces cardiomyocyte hypertrophy, inflammation and systolic heart failure.
Lovett DH; Mahimkar R; Raffai RL; Cape L; Zhu BQ; Jin ZQ; Baker AJ; Karliner JS
PLoS One; 2013; 8(7):e68154. PubMed ID: 23874529
[TBL] [Abstract][Full Text] [Related]
34. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
[TBL] [Abstract][Full Text] [Related]
35. Deficiency of ataxia-telangiectasia mutated kinase modulates functional and biochemical parameters of the heart in response to Western-type diet.
Wingard MC; Dalal S; Shook PL; Myers R; Connelly BA; Thewke DP; Singh M; Singh K
Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2324-H2338. PubMed ID: 33929897
[TBL] [Abstract][Full Text] [Related]
36. ET(A)-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat.
Podesser BK; Siwik DA; Eberli FR; Sam F; Ngoy S; Lambert J; Ngo K; Apstein CS; Colucci WS
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H984-91. PubMed ID: 11179039
[TBL] [Abstract][Full Text] [Related]
37. Protein tyrosine phosphatase 1B inactivation limits aging-associated heart failure in mice.
Besnier M; Coquerel D; Favre J; Dumesnil A; Guerrot D; Remy-Jouet I; Mulder P; Djerada Z; Tamion F; Richard V; Ouvrard-Pascaud A
Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1279-H1288. PubMed ID: 29569957
[TBL] [Abstract][Full Text] [Related]
38. Age-related differences in postinfarct left ventricular rupture and remodeling.
Yang Y; Ma Y; Han W; Li J; Xiang Y; Liu F; Ma X; Zhang J; Fu Z; Su YD; Du XJ; Gao XM
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1815-22. PubMed ID: 18263717
[TBL] [Abstract][Full Text] [Related]
39. Cardiac-restricted overexpression of membrane type-1 matrix metalloproteinase in mice: effects on myocardial remodeling with aging.
Spinale FG; Escobar GP; Mukherjee R; Zavadzkas JA; Saunders SM; Jeffords LB; Leone AM; Beck C; Bouges S; Stroud RE
Circ Heart Fail; 2009 Jul; 2(4):351-60. PubMed ID: 19808359
[TBL] [Abstract][Full Text] [Related]
40. Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias.
Frey N; Franz WM; Gloeckner K; Degenhardt M; Müller M; Müller O; Merz H; Katus HA
Cardiovasc Res; 2000 Aug; 47(2):254-64. PubMed ID: 10946062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
